ADOCTIDE
Therapeutic Class: Anti-Neoplastic
Indication: Acromegaly, Metastatic Carcinoid Tumors, VIPomas
Acromegaly: excess GH/IGF-1 production, usually from a pituitary adenoma. Also used for symptom control in metastatic carcinoid tumors and VIPomas
As directed by Physician
30 mg long-acting release injection
2–8°C, refrigerated and protected from light. Bring kit to room temperature for 30–60 min before preparation; administer suspension immediately after mixing
